Technical Analysis for SGTX - Sigilon Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 35.46 3.81% 1.30
SGTX closed up 3.81 percent on Friday, January 15, 2021, on 71 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong N/A N/A Flat
Historical SGTX trend table...

Date Alert Name Type % Chg
Stochastic Buy Signal Bullish 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 3.81%
Hot IPO Pullback Bullish Swing Setup 3.81%
Narrow Range Bar Range Contraction 3.81%
NR7 Range Contraction 3.81%
NR7-2 Range Contraction 3.81%
Doji - Bullish? Reversal 3.81%
Wide Bands Range Expansion 3.81%
Older End-of-Day Signals for SGTX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakout about 9 hours ago
Rose Above 10 DMA about 10 hours ago
Up 5% about 11 hours ago
Hot IPO Pullback Entry about 12 hours ago
1,2,3, Pullback Entry about 12 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Sigilon Therapeutics, Inc., a biopharmaceutical company, develops functional cures for patients with chronic diseases. Its lead product candidate is SIG-001, which is in Phase I/II clinical trial to prevent bleeding episodes in patients with moderate-severe to severe Hemophilia A. The company is also developing SIG-005 to treat the non-neurological manifestations of the disease in patients with mucopolysaccharidosis type 1; and SIG-002 designed to replace islet cells for the treatment of type 1 diabetes. The company was formerly known as Sigilon, Inc. and changed its name to Sigilon Therapeutics, Inc. in June 2017. Sigilon Therapeutics, Inc. was founded in 2015 and is headquartered in Cambridge, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Life Sciences Disease Diabetes Health Sciences Hemophilia Chronic Disease Chronic Diseases Hemophilia A Mucopolysaccharidosis Haemophilia Mucopolysaccharidosis Type

Is SGTX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 54.32
52 Week Low 22.0
Average Volume 140,417
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 37.64
10-Day Moving Average 35.60
Average True Range 4.63
ADX 43.28
+DI 26.79
-DI 12.32
Chandelier Exit (Long, 3 ATRs ) 40.43
Chandelier Exit (Short, 3 ATRs ) 40.19
Upper Bollinger Band 45.79
Lower Bollinger Band 29.48
Percent B (%b) 0.37
BandWidth 43.32
MACD Line 0.69
MACD Signal Line 1.47
MACD Histogram -0.7811
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 39.02
Resistance 3 (R3) 39.10 37.99 38.42
Resistance 2 (R2) 37.99 37.09 37.95 38.22
Resistance 1 (R1) 36.73 36.53 37.36 36.65 38.03
Pivot Point 35.62 35.62 35.94 35.58 35.62
Support 1 (S1) 34.36 34.72 34.99 34.28 32.89
Support 2 (S2) 33.25 34.16 33.21 32.70
Support 3 (S3) 31.99 33.25 32.50
Support 4 (S4) 31.91